Chattanooga Times Free Press

Trump touts U. S. vaccine progress

- BY ZEKE MILLER, KEVIN FREKING AND AAMER MADHANI

WASHINGTON — Gliding over significan­t challenges still to come, President Donald Trump on Friday offered a rosy update on the race for a vaccine for the resurgent coronaviru­s as he delivered his first public remarks since his defeat by President- elect Joe Biden. He still did not concede the election.

Trump spoke from the Rose Garden as the nation sets records for confirmed cases of COVID19, and as hospitaliz­ations near critical levels and fatalities climb to the highest levels since the spring. He said a vaccine would ship in “a matter of weeks” to vulnerable population­s, though the Food and Drug Administra­tion has not yet been asked to grant the necessary emergency approvals.

Public health experts worry that Trump’s refusal to take aggressive action on the pandemic or to coordinate with the Biden team during the final two months of his presidency will only worsen the effects of the virus and hinder the nation’s ability to swiftly distribute a vaccine next year.

As states impose new restrictio­ns in the face of rising caseloads, Trump asked all Americans to remain “vigilant.” But he ruled out a nationwide “lockdown” and appeared to acknowledg­e that the decision won’t be his much longer.

“This administra­tion will not be going to a lockdown,” he said. “Hopefully whatever happens in the future, who knows, which administra­tion it will be I guess time will tell, but I can tell you this administra­tion will not go to a lockdown.”

Biden, for his part, has not endorsed a nationwide shutdown, but he appealed for Trump to take “urgent action” to curtail the spread of the virus. “The crisis does not respect dates on the calendar, it is accelerati­ng right now,” he said in a statement Friday.

Trump said vaccines would “arrive within a few weeks,” saying they were ready and merely awaiting approval — and would be given “to high- risk individual­s right away.” In fact, there’s no guarantee that Pfizer’s shot, the front-runner, will get rapid authorizat­ion for emergency use. Even if it does, there’s no informatio­n yet indicating if the vaccine works in older adults or just younger, healthier adults. Nor does Pfizer have a large commercial stockpile already poised to ship; initial batches of shots would be small and targeted to certain still-to-be-determined population­s.

Trump took no questions Friday from reporters. He hasn’t answered questions since before Election Day.

Meanwhile, his campaign prediction that the U. S. was “rounding the turn” on the pandemic has met a harsh reality, with his own White House becoming the focus of yet another outbreak.

Trump’s aggressive travel despite the virus has taken its toll on his protectors as well. The U. S. Secret Service is experienci­ng a significan­t number of cases, many believed to be linked to his rallies in the closing days of the campaign, according to one official.

White House press secretary Kayleigh McEnany, meanwhile, said Trump is “not even at that point yet” when it comes to conceding to Biden. Trump has leveled baseless allegation­s of widespread voter fraud, even as his own administra­tion has said there is no evidence to support the claims. His aides suggest he is merely trying to keep his base of supporters on his side in defeat.

Trump spoke with conservati­ve media on Friday, including Fox News’ Geraldo Rivera, suggesting he would acknowledg­e the loss only after exhausting his legal options.

“You know, he told me he was a realist,” Rivera said. “He told me he would do the right thing.”

With more than 100,000 new confirmed U.S. cases reported daily for more than a week, Trump has been more focused on tracking the rollout of a vaccine, which won’t be widely available for months.

 ?? AP PHOTO/ EVAN VUCCI ?? President Donald Trump speaks in the Rose Garden of the White House on Friday in Washington.
AP PHOTO/ EVAN VUCCI President Donald Trump speaks in the Rose Garden of the White House on Friday in Washington.

Newspapers in English

Newspapers from United States